«New therapies for ALS are urgently needed — and our creation of human models using iPS cell technology will
hopefully deepen our understanding of how the disease develops — and lead to relevant therapies for patients,» said Senior Investigator Steve Finkbeiner, MD, PhD, who leads ALS research at Gladstone.